How to achieve international action on falsified and substandard medicines

BMJ 2012; 345 doi: (Published 13 November 2012)
Cite this as: BMJ 2012;345:e7381

Related articles

Letter: European Union has the Falsified Medicines Directive

Editor's Choice: Time for global action on fake and substandard drugs

Feature: Faking it

Analysis: Commentary: Substandard medicines are the priority for neglected tropical diseases

Feature: Meningitis outbreak shines light on compounding pharmacies

Editorial: Murder by fake drugs

See more

Practice: Ordering and interpreting hepatitis B serology

News: Tamiflu purchase worth £49m will go ahead, government says

Clinical Review: Anticoagulation in atrial fibrillation

News: Cochrane review questions effectiveness of neuraminidase inhibitors

This article has been cited by other articles: